Cwm LLC Raises Stock Holdings in CME Group Inc. (NASDAQ:CME)

Cwm LLC boosted its holdings in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 1.5% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 21,618 shares of the financial services provider’s stock after purchasing an additional 329 shares during the quarter. Cwm LLC’s holdings in CME Group were worth $4,654,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Kestra Advisory Services LLC grew its stake in CME Group by 86.6% in the third quarter. Kestra Advisory Services LLC now owns 5,763 shares of the financial services provider’s stock worth $1,154,000 after purchasing an additional 2,675 shares in the last quarter. V Square Quantitative Management LLC grew its position in shares of CME Group by 102.8% in the 3rd quarter. V Square Quantitative Management LLC now owns 2,028 shares of the financial services provider’s stock worth $406,000 after acquiring an additional 1,028 shares in the last quarter. Azimuth Capital Investment Management LLC increased its holdings in shares of CME Group by 2.3% in the 3rd quarter. Azimuth Capital Investment Management LLC now owns 9,533 shares of the financial services provider’s stock valued at $1,909,000 after acquiring an additional 215 shares during the last quarter. Regal Investment Advisors LLC raised its position in shares of CME Group by 23.2% during the 3rd quarter. Regal Investment Advisors LLC now owns 14,930 shares of the financial services provider’s stock valued at $2,989,000 after acquiring an additional 2,807 shares in the last quarter. Finally, Dark Forest Capital Management LP lifted its stake in CME Group by 7.8% during the third quarter. Dark Forest Capital Management LP now owns 11,926 shares of the financial services provider’s stock worth $2,388,000 after purchasing an additional 865 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Argus increased their target price on shares of CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a report on Wednesday, March 6th. Keefe, Bruyette & Woods raised their target price on shares of CME Group from $222.00 to $226.00 and gave the stock a “market perform” rating in a report on Thursday, April 25th. Rosenblatt Securities reaffirmed a “sell” rating and set a $187.00 target price (up from $185.00) on shares of CME Group in a report on Thursday, April 25th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $210.00 price objective (down previously from $235.00) on shares of CME Group in a research report on Friday, April 5th. Finally, Bank of America increased their target price on CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a research report on Thursday, April 25th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, CME Group presently has a consensus rating of “Hold” and a consensus price target of $217.80.

Get Our Latest Analysis on CME

CME Group Stock Performance

Shares of CME traded down $0.06 during trading hours on Wednesday, reaching $196.53. 2,225,155 shares of the company’s stock traded hands, compared to its average volume of 1,896,873. CME Group Inc. has a twelve month low of $177.97 and a twelve month high of $223.80. The business’s fifty day simple moving average is $207.54 and its two-hundred day simple moving average is $209.65. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a market capitalization of $70.76 billion, a price-to-earnings ratio of 22.36, a P/E/G ratio of 5.20 and a beta of 0.52.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings data on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.44 by $0.06. The business had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The business’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter last year, the business earned $2.42 earnings per share. Analysts predict that CME Group Inc. will post 9.72 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Friday, June 7th will be issued a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a dividend yield of 2.34%. The ex-dividend date of this dividend is Friday, June 7th. CME Group’s dividend payout ratio is 52.33%.

Insider Activity at CME Group

In other news, Director Charles P. Carey sold 3,000 shares of the business’s stock in a transaction that occurred on Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now owns 7,163 shares in the company, valued at $1,399,936.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Charles P. Carey sold 3,000 shares of the stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the completion of the sale, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Terrence A. Duffy sold 40,000 shares of the stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $210.91, for a total transaction of $8,436,400.00. Following the completion of the sale, the chief executive officer now directly owns 67,455 shares of the company’s stock, valued at $14,226,934.05. The disclosure for this sale can be found here. Insiders sold 54,290 shares of company stock worth $11,393,700 in the last quarter. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.